Detalhe da pesquisa
1.
Lysine-Derived Charge-Altering Releasable Transporters: Targeted Delivery of mRNA and siRNA to the Lungs.
Bioconjug Chem
; 2023 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36996808
2.
Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens.
Nature
; 543(7647): 723-727, 2017 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28329770
3.
Fingolimod-Conjugated Charge-Altering Releasable Transporters Efficiently and Specifically Deliver mRNA to Lymphocytes In Vivo and In Vitro.
Biomacromolecules
; 23(7): 2976-2988, 2022 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35748182
4.
mRNA vaccination with charge-altering releasable transporters elicits human T cell responses and cures established tumors in mice.
Proc Natl Acad Sci U S A
; 115(39): E9153-E9161, 2018 09 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-30201728
5.
Oligo(serine ester) Charge-Altering Releasable Transporters: Organocatalytic Ring-Opening Polymerization and their Use for in Vitro and in Vivo mRNA Delivery.
J Am Chem Soc
; 141(21): 8416-8421, 2019 05 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31083999
6.
An mRNA SARS-CoV-2 vaccine employing Charge-Altering Releasable Transporters with a TLR-9 agonist induces neutralizing antibodies and T cell memory.
bioRxiv
; 2021 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33880472
7.
An mRNA SARS-CoV-2 Vaccine Employing Charge-Altering Releasable Transporters with a TLR-9 Agonist Induces Neutralizing Antibodies and T Cell Memory.
ACS Cent Sci
; 7(7): 1191-1204, 2021 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34341771
8.
Charge-altering releasable transporters enable phenotypic manipulation of natural killer cells for cancer immunotherapy.
Blood Adv
; 4(17): 4244-4255, 2020 09 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32898247
9.
Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trial.
J Exp Med
; 217(9)2020 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32558897